Evaluating the Use of Glucocorticoids Among Belimumab‐Treated Patients With Systemic Lupus Erythematosus in Real‐World Settings Using the Rheumatology Informatics System for Effectiveness Registry
Author:
Affiliation:
1. University of California San Francisco
2. GlaxoSmithKline, Research Triangle Park North Carolina
3. GSK Brentford Middlesex UK
4. San Francisco and San Francisco Veteran Affairs Medical Center University of California
Publisher
Wiley
Subject
Rheumatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11482
Reference21 articles.
1. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
2. Guidelines for referral and management of systemic lupus erythematosus in adults
3. GSK.Benlysta prescribing information.2020. URL:https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125370s068 761043s008lbl 761043s013lbl.pdf.
4. European Medicines Agency.Benlysta summary of product characteristics.2020. URL:https://www.ema.europa.eu/en/documents/product-information/benlysta-epar-product-information_en.pdf.
5. GSK.China's National Medical Products Administration approves Benlysta (belimumab) for adult patients with active lupus nephritis.2022. URL:https://www.gsk.com/en‐gb/media/press‐releases/china‐s‐national‐medical‐products‐administration‐approves‐benlysta‐belimumab‐for‐adult‐patients‐with‐active‐lupus‐nephritis.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. No clear influence of treatment escalation on flare prevention in serologically active clinically quiescent patients with systemic lupus erythematosus: a retrospective cohort study;Rheumatology International;2024-04-26
2. Systemic lupus erythematosus with juvenile onset: current status of the problem (literature review);Modern Rheumatology Journal;2024-04-22
3. Glucocorticoid-free remission in patients with SLE in the era of biologics: Immune complex disease is likely to benefit from current medications;Lupus;2024-03-12
4. Belimumab in a Patient with Systemic Lupus Erythematosus with Juvenile Onset and Steroid-induced Diabetes: Clinical Case;Current Pediatrics;2024-01-12
5. Disease-modifying effect and long-term safety of belimumab in patients with systemic lupus erythematosus: A single-center retrospective study;Lupus;2023-10-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3